| P2093 | author name string | Giuseppe Orlando | |
| | Jeffrey Rogers | |
| | Robert J Stratta | |
| | Alan C Farney | |
| | Amudha Palanisamy | |
| | Michael D Gautreaux | |
| | Amber Reeves-Daniel | |
| | Samy S Iskandar | |
| | Scott Kaczmorski | |
| | William Doares | |
| P2860 | cites work | Lessons learned from more than 1,000 pancreas transplants at a single institution | Q24541751 |
| | OPTN/SRTR 2011 Annual Data Report: pancreas | Q30581468 |
| | 2011 update on pancreas transplantation: comprehensive trend analysis of 25,000 cases followed up over the course of twenty-four years at the International Pancreas Transplant Registry (IPTR) | Q35128342 |
| | Pancreas transplantation: lessons learned from a decade of experience at Wake Forest Baptist Medical Center | Q35128345 |
| | Simultaneous pancreas-kidney transplants in type I and type II diabetic patients with end-stage renal disease: similar 10-year outcomes | Q36105136 |
| | Experience with alternate-day thymoglobulin induction in pancreas transplantation with portal-enteric drainage | Q36317902 |
| | Banff schema for grading pancreas allograft rejection: working proposal by a multi-disciplinary international consensus panel | Q37150365 |
| | A comparison of alemtuzumab with basiliximab induction in simultaneous pancreas-kidney transplantation. | Q37241198 |
| | Pancreas transplantation in the United States: a review | Q37654089 |
| | The pancreas allograft donor: current status, controversies, and challenges for the future | Q37729275 |
| | Pancreas transplantation for type 2 diabetes mellitus | Q37819952 |
| | Pancreas graft thrombosis: causes, prevention, diagnosis, and intervention | Q37970219 |
| | Immunosuppression for pancreas transplantation with an emphasis on antibody induction strategies: review and perspective | Q38162892 |
| | Pancreas transplantation with portal venous drainage with an emphasis on technical aspects | Q38177374 |
| | Banff 07 classification of renal allograft pathology: updates and future directions | Q40121163 |
| | Alemtuzumab induction and tacrolimus monotherapy in pancreas transplantation: One- and two-year outcomes | Q42150369 |
| | Simultaneous pancreas kidney transplants in diabetic patients with end-stage renal disease: the 20-yr experience | Q44696384 |
| | President's Address. The Transplantation Society--Berlin 2012. | Q45746801 |
| | Experience with protocol biopsies after solitary pancreas transplantation | Q46264343 |
| | Outcome of untreated grade II rejection on solitary pancreas allograft biopsy specimens | Q46562310 |
| | Do pretransplant C-peptide levels influence outcomes in simultaneous kidney-pancreas transplantation? | Q46676052 |
| | Outcomes of pancreas transplants for patients with type 2 diabetes mellitus | Q46824247 |
| | A randomized trial of alemtuzumab versus antithymocyte globulin induction in renal and pancreas transplantation. | Q54286979 |
| | Histologic grading of acute allograft rejection in pancreas needle biopsy: correlation to serum enzymes, glycemia, and response to immunosuppressive treatment | Q77781320 |
| | Chronic rejection: the next major challenge for pancreas transplant recipients | Q79080629 |
| | Experience in renal and extrarenal transplantation with donation after cardiac death donors with selective use of extracorporeal support | Q81253630 |
| | An analysis of the lack of donor pancreas utilization from younger adult organ donors | Q84513035 |
| | Import pancreas allografts: good from far or far from good? | Q84536439 |
| P433 | issue | 6 | |
| P921 | main subject | pancreas | Q9618 |
| P304 | page(s) | 951-961 | |
| P577 | publication date | 2014-12-01 | |
| P1433 | published in | World journal of diabetes | Q27723539 |
| P1476 | title | Pancreas transplantation: The Wake Forest experience in the new millennium | |
| P478 | volume | 5 | |